# Citius Oncology (CTOR) — Earnings

CTOR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ctor/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.08 |
| EPS estimate | −$0.15 |
| EPS surprise | +46.67% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 12, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1851484/000121390025074992/ea0252318-10q_citius.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Aug 12, 2025 | −$0.15 | −$0.08 | 46.67% | — | — |
| Q2 2025 | May 14, 2025 | −$0.09 | −$0.11 | -22.22% | $5.7M | — |
| Q1 2025 | Feb 14, 2025 | −$0.06 | −$0.09 | -50.00% | — | — |

## Frequently Asked Questions

### When did Citius Oncology (CTOR) last report earnings?

Citius Oncology last reported on Aug 12, 2025, covering fiscal Q3 2025.

### Did CTOR beat earnings estimates?

Yes. Citius Oncology reported EPS of −$0.08 for Q3 2025 against a −$0.15 estimate — a 46.67% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).